Edwards Lifesciences gains amid takeover speculation

Edwards Lifesciences facility in Draper, Utah, USA

JHVEPhoto

  • Edwards Lifesciences (NYSE:EW) quickly rose 2.8% amid some vague takeover speculation.
  • Edwards (EW) may have attracted takeover interest from an unnamed suitor, according to traders, who cited a Betaville “uncooked alert” circulating on Monday.
  • Edwards Lifesciences (EW) has a market cap of $41 billion.

Leave a Reply

Your email address will not be published. Required fields are marked *